Covaxin effective against Delta Variant of Covid
According to the NIH, the findings show that the vaccine generates antibodies that successfully neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) forms of SARS-CoV-2, which were initially discovered in the UK and India, respectively.